Literature DB >> 24067971

Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.

Remo Leisi1, Nico Ruprecht, Christoph Kempf, Carlos Ros.   

Abstract

The VP1 unique region (VP1u) of human parvovirus B19 (B19V) is the immunodominant part of the viral capsid. Originally inaccessible, the VP1u becomes exposed upon primary attachment to the globoside receptor. To study the function of the exposed VP1u in B19V uptake, we expressed this region as a recombinant protein. Here, we report that purified recombinant VP1u binds and is internalized in UT7/Epo cells. By means of truncations and specific antibodies, we identified the most N-terminal amino acid residues of VP1u as the essential region for binding and internalization. Furthermore, the recombinant VP1u was able to block B19V uptake, suggesting that the protein and the virus undertake the same internalization pathway. Assays with different erythroid and nonerythroid cell lines showed that the N-terminal VP1u binding was restricted to a few cell lines of the erythroid lineage, which were also the only cells that allowed B19V internalization and infection. These results together indicate that the N-terminal region of VP1u is responsible for the internalization of the virus and that the interacting receptor is restricted to B19V-susceptible cells. The highly selective uptake mechanism represents a novel determinant of the tropism and pathogenesis of B19V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067971      PMCID: PMC3838272          DOI: 10.1128/JVI.02548-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19.

Authors:  J Brunstein; M Söderlund-Venermo; K Hedman
Journal:  Virology       Date:  2000-09-01       Impact factor: 3.616

2.  BioImageXD: an open, general-purpose and high-throughput image-processing platform.

Authors:  Pasi Kankaanpää; Lassi Paavolainen; Silja Tiitta; Mikko Karjalainen; Joacim Päivärinne; Jonna Nieminen; Varpu Marjomäki; Jyrki Heino; Daniel J White
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

3.  The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.

Authors:  Simone Dorsch; Gerhard Liebisch; Bärbel Kaufmann; Philipp von Landenberg; Jörg H Hoffmann; Wolfgang Drobnik; Susanne Modrow
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection.

Authors:  Maija Vihinen-Ranta; Dai Wang; Wendy S Weichert; Colin R Parrish
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability.

Authors:  Simone Dorsch; Bärbel Kaufmann; Uwe Schaible; Elke Prohaska; Hans Wolf; Susanne Modrow
Journal:  J Gen Virol       Date:  2001-01       Impact factor: 3.891

6.  The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.

Authors:  Anne Girod; Christiane E Wobus; Zoltán Zádori; Martin Ried; Kristin Leike; Peter Tijssen; Jürgen A Kleinschmidt; Michael Hallek
Journal:  J Gen Virol       Date:  2002-05       Impact factor: 3.891

7.  A viral phospholipase A2 is required for parvovirus infectivity.

Authors:  Z Zádori; J Szelei; M C Lacoste; Y Li; S Gariépy; P Raymond; M Allaire; I R Nabi; P Tijssen
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

8.  Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.

Authors:  K A Weigel-Kelley; M C Yoder; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 9.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry.

Authors:  Kirsten A Weigel-Kelley; Mervin C Yoder; Arun Srivastava
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  26 in total

1.  VP2 capsid domain of the H-1 parvovirus determines susceptibility of human cancer cells to H-1 viral infection.

Authors:  I-R Cho; S Kaowinn; J Song; S Kim; S S Koh; H-Y Kang; N-C Ha; K H Lee; H-S Jun; Y-H Chung
Journal:  Cancer Gene Ther       Date:  2015-04-10       Impact factor: 5.987

2.  Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.

Authors:  Jan Bieri; Carlos Ros
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

3.  Human parvovirus B19: a mechanistic overview of infection and DNA replication.

Authors:  Yong Luo; Jianming Qiu
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

4.  Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody.

Authors:  Yingyuan Sun; Thomas Klose; Yue Liu; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

Review 5.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 6.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

7.  High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors.

Authors:  Kang Ning; Anuradha Roy; Fang Cheng; Peng Xu; Steve Kleiboeker; Carlos R Escalante; Jingxin Wang; Jianming Qiu
Journal:  J Virol       Date:  2021-10-20       Impact factor: 6.549

8.  Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.

Authors:  Tsai-Ching Hsu; Chun-Ching Chiu; Shun-Chih Chang; Hsu-Chin Chan; Ya-Fang Shi; Tzy-Yen Chen; Bor-Show Tzang
Journal:  Virulence       Date:  2015-12-02       Impact factor: 5.882

9.  The N-terminal 5-68 amino acids domain of the minor capsid protein VP1 of human parvovirus B19 enters human erythroid progenitors and inhibits B19 infection.

Authors:  Wei Zou; Kang Ning; Peng Xu; Xuefeng Deng; Fang Cheng; Steve Kleiboeker; Jianming Qiu
Journal:  J Virol       Date:  2021-05-05       Impact factor: 5.103

Review 10.  Role of capsid proteins in parvoviruses infection.

Authors:  Mengyu Tu; Fei Liu; Shun Chen; Mingshu Wang; Anchun Cheng
Journal:  Virol J       Date:  2015-08-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.